{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:03:17Z","timestamp":1787313797426,"version":"build-2736575974"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100013327","name":"Lundbeck","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100013327","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12883-017-0867-5","type":"journal-article","created":{"date-parts":[[2017,5,11]],"date-time":"2017-05-11T21:48:30Z","timestamp":1494539310000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":77,"title":["Integrated analysis of droxidopa trials for neurogenic orthostatic hypotension"],"prefix":"10.1186","volume":"17","author":[{"given":"Italo","family":"Biaggioni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Arthur Hewitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald J.","family":"Rowse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horacio","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,12]]},"reference":[{"key":"867_CR1","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1093\/oxfordjournals.aje.a008690","volume":"143","author":"WC Graafmans","year":"1996","unstructured":"Graafmans WC, Ooms ME, Hofstee HM, Bezemer PD, Bouter LM, Lips P. Falls in the elderly: a prospective study of risk factors and risk profiles. Am J Epidemiol. 1996;143:1129\u201336.","journal-title":"Am J Epidemiol"},{"key":"867_CR2","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1532-5415.2011.03317.x","volume":"59","author":"A Gangavati","year":"2011","unstructured":"Gangavati A, Hajjar I, Quach L, Jones RN, Kiely DK, Gagnon P, et al. Hypertension, orthostatic hypotension, and the risk of falls in a community-dwelling elderly population: the maintenance of balance, independent living, intellect, and zest in the elderly of Boston study. J Am Geriatr Soc. 2011;59:383\u20139.","journal-title":"J Am Geriatr Soc"},{"key":"867_CR3","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1161\/CIRCULATIONAHA.105.598722","volume":"114","author":"KM Rose","year":"2006","unstructured":"Rose KM, Eigenbrodt ML, Biga RL, Couper DJ, Light KC, Sharrett AR, et al. Orthostatic hypotension predicts mortality in middle-aged adults: the Atherosclerosis Risk In Communities (ARIC) Study. Circulation. 2006;114:630\u20136.","journal-title":"Circulation"},{"key":"867_CR4","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1093\/ajh\/hpv022","volume":"28","author":"N Veronese","year":"2015","unstructured":"Veronese N, De Rui M, Bolzetta F, Zambon S, Corti MC, Baggio G, et al. Orthostatic changes in blood pressure and mortality in the elderly: the Pro.V.A Study. Am J Hypertens. 2015;28:1248\u201356.","journal-title":"Am J Hypertens"},{"key":"867_CR5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/eurheartj\/ehp329","volume":"31","author":"A Fedorowski","year":"2010","unstructured":"Fedorowski A, Stavenow L, Hedblad B, Berglund G, Nilsson PM, Melander O. Orthostatic hypotension predicts all-cause mortality and coronary events in middle-aged individuals (The Malmo Preventive Project). Eur Heart J. 2010;31:85\u201391.","journal-title":"Eur Heart J"},{"key":"867_CR6","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10286-011-0119-5","volume":"21","author":"R Freeman","year":"2011","unstructured":"Freeman R, Wieling W, Axelrod FB, Benditt DG, Benarroch E, Biaggioni I, et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res. 2011;21:69\u201372.","journal-title":"Clin Auton Res"},{"key":"867_CR7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1161\/CIRCULATIONAHA.108.805887","volume":"119","author":"DS Goldstein","year":"2009","unstructured":"Goldstein DS, Sharabi Y. Neurogenic orthostatic hypotension: a pathophysiological approach. Circulation. 2009;119:139\u201346.","journal-title":"Circulation"},{"key":"867_CR8","unstructured":"Northera (droxidopa). Full Prescribing Information, Lundbeck NA Ltd, Deerfield, IL, 2014."},{"key":"867_CR9","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1586\/14779072.2015.1057504","volume":"13","author":"H Kaufmann","year":"2015","unstructured":"Kaufmann H, Norcliffe-Kaufmann L, Palma JA. Droxidopa in neurogenic orthostatic hypotension. Expert Rev Cardiovasc Ther. 2015;13:875\u201391.","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"867_CR10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1161\/HYPERTENSIONAHA.114.04035","volume":"65","author":"I Biaggioni","year":"2015","unstructured":"Biaggioni I, Freeman R, Mathias CJ, Low P, Hewitt LA, Kaufmann H, et al. Randomized withdrawal study of patients with symptomatic neurogenic orthostatic hypotension responsive to droxidopa. Hypertension. 2015;65:101\u20137.","journal-title":"Hypertension"},{"key":"867_CR11","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1212\/WNL.0000000000000615","volume":"83","author":"H Kaufmann","year":"2014","unstructured":"Kaufmann H, Freeman R, Biaggioni I, Low P, Pedder S, Hewitt LA, et al. Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial. Neurology. 2014;83:328\u201335.","journal-title":"Neurology"},{"key":"867_CR12","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/mds.26086","volume":"30","author":"RA Hauser","year":"2015","unstructured":"Hauser RA, Isaacson S, Lisk JP, Hewitt LA, Rowse G. Droxidopa for the short-term treatment of symptomatic neurogenic orthostatic hypotension in Parkinson's disease (NOH306B). Mov Disord. 2015;30:646\u201354.","journal-title":"Mov Disord"},{"key":"867_CR13","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3233\/JPD-130259","volume":"4","author":"RA Hauser","year":"2014","unstructured":"Hauser RA, Hewitt LA, Isaacson S. Droxidopa in patients with neurogenic orthostatic hypotension associated with Parkinson's disease (NOH306A). J Parkinsons Dis. 2014;4:57\u201365.","journal-title":"J Parkinsons Dis."},{"key":"867_CR14","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10286-011-0146-2","volume":"22","author":"H Kaufmann","year":"2012","unstructured":"Kaufmann H, Malamut R, Norcliffe-Kaufmann L, Rosa K, Freeman R. The Orthostatic Hypotension Questionnaire (OHQ): validation of a novel symptom assessment scale. Clin Auton Res. 2012;22:79\u201390.","journal-title":"Clin Auton Res"},{"key":"867_CR15","unstructured":"Guy W. ECDEU Assessment Manual for Psychopharmacology. Rockville: US Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute of Mental Health, Psychopharmacology Research Branch, Division of Extramural Research Programs; 1976."},{"key":"867_CR16","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1586\/14737167.2.2.119","volume":"2","author":"MR Hufford","year":"2002","unstructured":"Hufford MR, Shiffman S. Methodological issues affecting the value of patient-reported outcomes data. Expert Rev Pharmacoecon Outcomes Res. 2002;2:119\u201328.","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"867_CR17","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1161\/01.CIR.0000083721.49847.D7","volume":"108","author":"H Kaufmann","year":"2003","unstructured":"Kaufmann H, Saadia D, Voustianiouk A, Goldstein DS, Holmes C, Yahr MD, et al. Norepinephrine precursor therapy in neurogenic orthostatic hypotension. Circulation. 2003;108:724\u20138.","journal-title":"Circulation"},{"key":"867_CR18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10286-007-1005-z","volume":"18","author":"CJ Mathias","year":"2008","unstructured":"Mathias CJ. L-dihydroxyphenylserine (droxidopa) in the treatment of orthostatic hypotension: the European experience. Clin Auton Res. 2008;18:25\u20139.","journal-title":"Clin Auton Res"},{"key":"867_CR19","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/mds.26079","volume":"30","author":"JA Palma","year":"2015","unstructured":"Palma JA, Gomez-Esteban JC, Norcliffe-Kaufmann L, Martinez J, Tijero B, Berganzo K, et al. Orthostatic hypotension in Parkinson disease: how much you fall or how low you go? Mov Disord. 2015;30:639\u201345.","journal-title":"Mov Disord"},{"key":"867_CR20","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1007\/s11606-013-2520-3","volume":"28","author":"AK Parsaik","year":"2013","unstructured":"Parsaik AK, Singh B, Altayar O, Mascarenhas SS, Singh SK, Erwin PJ, et al. Midodrine for orthostatic hypotension: a systematic review and meta-analysis of clinical trials. J Gen Intern Med. 2013;28:1496\u2013503.","journal-title":"J Gen Intern Med"},{"key":"867_CR21","doi-asserted-by":"crossref","first-page":"751","DOI":"10.3233\/JPD-160860","volume":"6","author":"S Isaacson","year":"2016","unstructured":"Isaacson S, Shill HA, Vernino S, Ziemann A, Rowse GJ. Safety and durability of effect with long-term, open-label droxidopa treatment in patients with symptomatic neurogenic orthostatic hypotension (NOH303). J Parkinsons Dis. 2016;6:751\u20139.","journal-title":"J Parkinsons Dis"},{"key":"867_CR22","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.jash.2016.07.010","volume":"10","author":"S Isaacson","year":"2016","unstructured":"Isaacson S, Vernino S, Ziemann A, Rowse GJ, Kalu U, White WB. Long-term safety of droxidopa in patients with symptomatic neurogenic orthostatic hypotension. J Am Soc Hypertens. 2016;10:755\u201362.","journal-title":"J Am Soc Hypertens"},{"key":"867_CR23","unstructured":"Sustained effect of droxidopa in symptomatic neurogenic orthostatic hypotension (RESTORE; NCT02586623). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02586623?term=NCT02586623 . Accessed 9 Sept 2016."}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-017-0867-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T06:29:37Z","timestamp":1602052177000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-017-0867-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,12]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["867"],"URL":"https:\/\/doi.org\/10.1186\/s12883-017-0867-5","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,12]]},"article-number":"90"}}